@article{article, title  = {{The impact of tralokinumab on quality of life and school in patients aged 12–17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial}},

 publisher = {{National Society for Cutaneous Medicine}},

 url = {{http://dx.doi.org/10.25251/skin.6.supp.77 }},

 year = {{2022}},

 month = {{11}},

 author = {{Paller AS and Silverberg JI and Hong C-H and Cork M and Puig L and Arlert P and Kurbasic A and Soldbro L and Simpson EL}},

 doi = {{10.25251/skin.6.supp.77}},

 volume = {{6}},

 journal = {{SKIN The Journal of Cutaneous Medicine}},

 issue = {{6}},

 pages = {{s77-s77}},

 note = {{Accessed on 2024/12/22}}}